Last quarter (Q2 2022), M1 Kliniken AG's total revenue was €―, a decrease of ― from the same quarter last year. In Q2, M1 Kliniken AG's net income was €―. See M1 Kliniken AG’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	€ 314.61M	€ 159.59M	€ 77.22M	€ 65.21M	€ 47.19M
Cost of Revenue	-	€ 259.30M	€ 122.81M	€ 45.61M	€ 42.26M	€ 28.70M
Gross Profit	-	€ 55.31M	€ 36.78M	€ 31.61M	€ 22.95M	€ 18.50M
Operating Expense	-	€ 43.17M	€ 27.30M	€ 23.79M	€ 16.55M	€ 12.79M
Operating Income	-	€ 12.14M	€ 9.48M	€ 7.81M	€ 6.39M	€ 5.70M
Net Non Operating Interest Income Expense	-	€ -249.45K	€ -417.02K	€ -261.47K	€ 149.79K	€ 166.85K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	€ 14.42M	€ 8.78M	€ 12.74M	€ 8.09M	€ 7.35M
Tax Provision	-	€ 3.54M	€ 1.35M	€ 3.02M	€ 1.48M	€ 1.58M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	€ 8.91M	€ 6.82M	€ 9.73M	€ 6.61M	€ 5.78M
Basic EPS	-	€ 0.45	€ 0.37	€ 0.56	€ 0.39	€ 0.38
Diluted EPS	-	€ 0.45	€ 0.37	€ 0.56	€ 0.39	€ 0.38
Basic Average Shares	-	€ 19.64M	€ 18.58M	€ 17.50M	€ 16.81M	€ 15.36M
Diluted Average Shares	-	€ 19.64M	€ 18.58M	€ 17.50M	€ 16.81M	€ 16.50M
Dividend Per Share	-	€ 0.00	€ 0.00	€ 0.30	€ 0.30	€ 0.30
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	-	€ 302.47M	€ 150.11M	€ 69.40M	€ 58.81M	€ 41.49M
Net Income From Continuing And Discontinued Operation	-	€ 8.91M	€ 6.82M	€ 9.73M	€ 6.61M	€ 5.78M
Normalized Income	-	€ 7.63M	€ 5.66M	€ 7.15M	€ 6.56M	€ 4.61M
Interest Expense	-	€ 916.50K	€ 721.61K	€ 342.34K	€ 8.24K	€ 7.76K
EBIT	-	€ 15.34M	€ 9.50M	€ 13.09M	€ 8.10M	€ 7.36M
EBITDA	-	€ 21.03M	€ 13.98M	€ 16.49M	€ 8.81M	€ 7.82M

Currency in EUR

M1 Kliniken AG Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing